Cargando…
Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients
Background: Around 30% of all stage II colon cancer patients will relapse and die of their disease. At present no objective parameters to identify high-risk stage II colon cancer patients, who will benefit from adjuvant chemotherapy, have been established. With traditional histopathological features...
Autores principales: | Brosens, R. P. M., Belt, E. J. T. H., Haan, J. C., Buffart, T. E., Carvalho, B., Grabsch, H., Quirke, P., Cuesta, M. A., Engel, A. F., Ylstra, B., Meijer, G. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605565/ https://www.ncbi.nlm.nih.gov/pubmed/20966546 http://dx.doi.org/10.3233/ACP-CLO-2010-0531 |
Ejemplares similares
-
Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients
por: Brosens, R. P. M., et al.
Publicado: (2011) -
Mixed Gastric Carcinomas Show Similar Chromosomal Aberrations in Both their Diffuse and Glandular Components
por: Carvalho, Beatriz, et al.
Publicado: (2006) -
DNA Copy Number Changes at 8q11–24 in Metastasized Colorectal Cancer
por: Buffart, T. E., et al.
Publicado: (2005) -
DNA Quality Assessment for Array CGH by Isothermal Whole Genome Amplification
por: Buffart, Tineke E., et al.
Publicado: (2007) -
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
por: Buffart, Tineke E., et al.
Publicado: (2009)